U.S. Markets closed

Startup Battlefield Finals - CB Therapeutics | Disrupt SF 2018

CB Therapeutics has developed natural cannabinoids in yeast, using just sugar. Our patent-pending process eliminates the need for any plants, reduces the production cycle to just 5 days and reduces the production cost by many fold for each type of cannabinoid molecule. We have acquired a pilot production plant in California for scaling up and manufacturing in the coming months.